Multicenter study on the use of gemcitabine to prevent recurrence of multiple-recurring superficial bladder tumors following intravesical antiblastic agents and/or BCG: evaluation of tolerance.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples